By Ann Lefert, National Alliance of State and Territorial AIDS Directors and Bill McColl, AIDS United, Co-Chairs of the Ryan White Work Group, Federal AIDS Policy Partnership
As Co-Chairs of the Ryan White Work Group, we wanted to provide you with an update on the Ryan White Program. As you know, the current authorization ends on September 30, 2013. However, there is no “sunset” provision in the legislation. Therefore even if Congress does not take action, the Ryan White Program will remain a part of the law allowing funding to continue to be appropriated through the annual congressional appropriations process. Continue reading
By Meico Whitlock, Senior Manager, Communications
Every year since 1988, the National Minority AIDS Council (NMAC) has convened the annual United States Conference on AIDS (USCA). USCA brings together service providers, healthcare professionals, advocates, people living with HIV/AIDS, and policymakers.
This year, conference will be hosted in New Orleans, Louisiana and the focus will be on two major themes: the impact of the Affordable Care Act (ACA) on people living with HIV/AIDS (PLWHAs) and the need to improve the continuum of HIV care. The conference will also devote special attention to HIV/AIDS in the southern region of the U.S. Continue reading
FOR IMMEDIATE RELEASE
Contact: Meico Whitlock
August 26, 2013, Washington, DC – The ADAP Crisis Task Force (ACTF) has reached a new pricing agreement with ViiV Healthcare for AIDS Drug Assistance Programs (ADAPs) for Tivicay® (dolutegravir) for the treatment of HIV-1 infected individuals. The agreed-upon ADAP direct purchase price for Tivicay®, negotiated between the ACTF and ViiV, is substantially lower than the wholesale acquisition cost (WAC), reflecting voluntary discounts that are also significantly below the mandated 340B pricing of the medication.
By Meico Whitlock, Senior Manager, Communications, NASTAD
In May, during our 22nd Annual Meeting of state health department HIV and hepatitis program leaders in Washington, D.C., we hosted a discussion about the opportunities and challenges of addressing the prevention and care needs of gay men in the era of the National HIV/AIDS Strategy (NHAS), High Impact Prevention (HIP) and the Affordable Care Act (ACA). The following is an interview with Isaiah Webster, Senior Manager, Health Equity and Prevention at NASTAD, and James Markiewicz, Director, Maine HIV, STD, and Viral Hepatitis Program, who shared their reflections on the session. Continue reading
FOR IMMEDIATE RELEASE
Contact: Murray Penner
July 29, 2013, Washington, DC – As part of ongoing efforts by the ADAP Crisis Task Force (Task Force) and the pharmaceutical industry to address the continued need for access to HIV antiretroviral medicines through AIDS Drug Assistance Programs (ADAPs), the Task Force announced today that it has reached agreement with AbbVie, Gilead Sciences, Merck, and ViiV Healthcare to extend the voluntary discounts/rebates and price freezes available to all state ADAPs through December 31, 2014.